Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells

Journal of Vascular Research

Volumn 45, Issue 1, 2007, Pages 78-86

  Wu, Lian Qiu ^a   Zhang, Wen Jian ^a   Niu, Ji Xiao ^b   Ye, Li Ya ^a   Yang, Zhi Hua ^b   Grau, Georges E ^c   Lou, Jin Ning ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c University of Sydney   (Australia)

Author keywords

Adhesion molecule; Angiogenesis; Microvascular endothelial cells; Phenotype; TNF receptor

Indexed keywords

ALPHAVBETA5 INTEGRIN; BLOCKING ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; PROTEIN ANTIBODY; PROTEIN P55; PROTEIN P75; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; CAPILLARY; CELL FUNCTION; CELL PROLIFERATION; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME RELEASE; FIBRINOLYSIS; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHERENCE; LIVER CANCER; LIVER SINUSOID; MICROVASCULATURE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

CELL ADHESION; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHAVBETA3; INTEGRINS; INTERCELLULAR ADHESION MOLECULE-1; LIVER; LIVER NEOPLASMS; MATRIX METALLOPROTEINASES; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECEPTORS, VITRONECTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THROMBOPLASTIN; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA; URINARY PLASMINOGEN ACTIVATOR;

EID: 37249031843     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109079     Document Type: Article

References (23)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
2. Folkman J: Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-18.
3. Folkman J: Angiogenesis and angiogenesis inhibition: an overview. EXS 1997;79:1-8.
4. Ribatti D, Nico B, Vacca A, Roncali L, Dammacco F: Endothelial cell heterogeneity and organ specificity. J Hematother Stem Cell Res 2002;11:18-90.
5. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, St Croix B: Cell surface tumor endothelial markers are conserved in mice and humans. Cancer res 2001;61:6649-6655.
6. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, et al: Genes expressed in human tumor endothelium. Science 2000;289:1197-1202.
7. Bussolati B, Deambrosis I, Russo S, Deregibus MC, Camussi G: Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 2003;17:1159-1161.
8. Lou JN, Mili N, Decrind C, Donati Y, Kossodo S, Spiliopoulos A, et al: An improved method for isolation of microvascular endothelial cells from normal and inflamed human lung. In Vitro Cell Dev Biol Anim 1998;34:529-536.
9. Voyta JC, Via DP, Butterfield CE, Zetter BR: Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984;99:2034-2040.
10. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D: Reversible immortalization of human primary cells by lentivector-mediated transfer of specific genes. Mol Ther 2000;2:1-11.
11. Yang H, Majno P, Morel P, Toso C, Triponez F, Oberholzer J, et al: Prostaglandin E 1 protects human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 2002;64:94-103.
12. Caruso RA, Speciale G, Inferrera A, Rigoli L, Inferrera C: Ultrastructural observations on the microvasculature in advanced gastric carcinomas. Histol Histopathol 2001;16:785-792.
13. Brook PC, Clark RAF, Cheresh DA: Requirement of the vascular integrin αvβ3 for angiogenesis. Science 1994;263:569-571.
14. Reinmuth N, Liu W, Ahmad SA, Fan F, Stoeltzing O, Parikh AA, et al: αvβ3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Cancer Res 2003;63:2079-2087.
15. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213-216.
16. Lucas R, Lou JN, Juillard P, Moore M, Bluethmann H, Grau GE: Respective role of TNF receptors in the development of experimental cerebral malaria. J Neuroimmunol 1997;72:143-148.
17. Lucas R, Lou J, Morel DR, Ricou B, Suter PM, Grau GE: TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol 1997;61:551-558.
18. Kuzu I, Bicknell R, Fletcher CD, Gatter KC: Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab Invest 1993, 69:322-328.
19. Bell WR: The fibrinolytic system in neoplasia. Semin Thromb Hemost 1996;22:459-478.
20. De Cicco M: The prothrombotic state in cancer: pathogenic mechanisms. Crit Rev Oncol Hematol 2004;50:187-196.
21. Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, et al: Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998;152:399-411.
22. Hajjar KA, Deora A: New concepts in fibrinolysis and angiogenesis.Curr Atheroscler Rep 2000;2:417-421.
23. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, et al: Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 2000;97:3884-3889.